Drugplain

Juxtapid 20 mg/1

lomitapide mesylate · CAPSULE · Pharma Packaging Solutions, LLC dba Tjoapack LLC

No Recall History
Plain English

Juxtapid is a capsule containing lomitapide mesylate at 20 mg/1, taken oral. Manufactured by Pharma Packaging Solutions, LLC dba Tjoapack LLC.

Key Facts

Brand Name
Juxtapid
Generic Name
lomitapide mesylate
NDC Code (Product)
75929-027
Manufacturer
Pharma Packaging Solutions, LLC dba Tjoapack LLC
Strength
20 mg/1
Dosage Form
CAPSULE
Route
ORAL
Marketing Status
Application #
NDA203858
Marketing Start
01/03/2013

Recall History

No Recall History

Side Effects Reported to FDA

FDA FAERS database · These are reported events, not confirmed side effects

diarrhoea1,066 reports
weight decreased842 reports
therapy cessation792 reports
nausea551 reports
abdominal pain upper281 reports
flatulence241 reports
abdominal discomfort239 reports
vomiting216 reports
fatigue206 reports
off label use206 reports

Frequently Asked Questions

What is Juxtapid used for?

Juxtapid contains lomitapide mesylate. It is a capsule taken oral. Consult your doctor for specific uses.

Is Juxtapid a controlled substance?

Juxtapid is not classified as a controlled substance by the DEA.

What is the generic name for Juxtapid?

The generic name for Juxtapid is lomitapide mesylate. There are no other listed brand versions of lomitapide mesylate.

What is the NDC code for Juxtapid 20 mg/1?

The NDC (National Drug Code) for Juxtapid 20 mg/1 is 75929-027, listed by Pharma Packaging Solutions, LLC dba Tjoapack LLC.

Product NDC

75929-027

Package NDC

75929-027-25

Not medical advice. Always consult your doctor or pharmacist before making any medication decisions.

Data from openFDA · Public domain (CC0 1.0)